ASTRAZENECA Valuation

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>AP</div>
What is the value of ASTRAZENECA PHARMA today? ASTRAZENECA PHARMA prevailing Real Value cannot be determined due to lack of data. The current price of ASTRAZENECA PHARMA is 0.0. Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Our model approximates the value of ASTRAZENECA PHARMA from analyzing the firm fundamentals such as profit margin of 7.48 %, and return on equity of 19.88 % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor purchasing undervalued instruments and exiting overvalued instruments since, at some point future time, asset prices and their ongoing real values will blend.

Search Valuation

 
Refresh
ASTRAZENECA PHARMA Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as ASTRAZENECA PHARMA's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

ASTRAZENECA PHARMA Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining ASTRAZENECA PHARMA's current stock value. Our valuation model uses many indicators to compare ASTRAZENECA PHARMA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ASTRAZENECA PHARMA competition to find correlations between indicators driving ASTRAZENECA PHARMA's intrinsic value. More Info.
ASTRAZENECA PHARMA INDIA is number one stock in price to book category among related companies. It is number one stock in price to earning category among related companies reporting about  5.53  of Price to Earning per Price to Book.
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Check out Trending Equities. Please also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page